OncoSil Medical Ltd (AU:OSL) has released an update.
OncoSil Medical has announced the successful first treatment with their OncoSil™ device on a patient in Turkey, marking a significant step in their European market expansion strategy. The treatment, for locally advanced pancreatic cancer, was administered at Istanbul Memorial Hospital shortly after the appointment of EDH Nuclear Medicine & Healthcare Services as the distributor in Turkey. The device, which delivers targeted radiation therapy, has already been approved for sale in over 30 countries, including the European Union and the UK.
For further insights into AU:OSL stock, check out TipRanks’ Stock Analysis page.
